中东和非洲治疗性狗粮市场预测至 2028 年 - 按产品类型（干粮、湿/罐头食品、零食/零食等）和应用（体重管理、消化护理、过敏和免疫）划分的 COVID-19 影响和区域分析系统健康状况等）
No. of Pages: 101 | Report Code: TIPRE00026822 | Category: Food and Beverages
No. of Pages: 101 | Report Code: TIPRE00026822 | Category: Food and Beverages
治疗性饮食是为了满足宠物的特定需求而配制的，旨在对抗或预防疾病。饮食应包含碳水化合物、矿物质、蛋白质、脂肪、维生素和水的最佳组合。适当的营养有助于防止狗感染并保持其体型，同时使它们能够进行日常活动。狗粮制造商一直在推出适合狗生命各个阶段的产品。其中一些产品提供低过敏性营养，而其他配方则用于控制健康状况，例如肾脏和心脏相关疾病、胃肠道问题、牙科护理、体重控制、肝脏疾病和骨科疾病。治疗肾脏疾病的饮食中磷含量低，蛋白质含量适中。一些治疗皮肤病的饮食含有分解成小块的蛋白质，食用后不太可能刺激狗的免疫反应。因此，治疗性饮食对于维持狗的健康起着重要作用。
阿联酋和沙特阿拉伯等国家已登记了大量 COVID-19 患者横跨中东和非洲。 COVID-19 大流行已成为该地区最重大的挑战。中东和非洲贸易中断导致进口减少，加剧了医疗用品和其他商品的短缺，导致价格大幅上涨。由于出售治疗性狗粮的超市/大卖场关闭，大流行期间治疗性狗粮市场的增长出现下滑。因此，COVID-19 大流行对治疗性狗粮市场产生了负面影响。
随着新的进步和技术，供应商可以吸引新客户并扩大他们在新兴市场的足迹。这一因素可能会推动中东和非洲治疗性狗粮市场的发展。与人类相似，动物也患有慢性疾病。关节炎、慢性肾病、癌症、肝炎等肝脏疾病、皮肤过敏、糖尿病等是宠物常见的慢性疾病。癌症在伴侣动物和农场动物中越来越普遍。根据兽医癌症协会的数据，这种疾病是 47% 的狗，尤其是 10 岁以上的狗死亡的主要原因。此外，根据宠物癌症事实和数据，四分之一的狗在一生中会患上癌症。关节炎基金会表示，大约 20% 的成年狗患有关节炎。慢性疾病患病率的增长已成为狗主人的主要担忧，这凸显了对适当护理和饮食的需求。因此，随着狗的慢性疾病患病率不断上升，宠物食品公司正在专注于生产先进的治疗性和功能性食品，以帮助狗主人保持宠物的整体健康。
Strategic insights for Middle East and Africa Therapeutic Dog Food involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 266.70 Million |
| Market Size by 2028 | US$ 360.16 Million |
| Global CAGR (2021 - 2028) | 4.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Therapeutic Dog Food refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Therapeutic Dog Food Market is valued at US$ 266.70 Million in 2021, it is projected to reach US$ 360.16 Million by 2028.
As per our report Middle East and Africa Therapeutic Dog Food Market, the market size is valued at US$ 266.70 Million in 2021, projecting it to reach US$ 360.16 Million by 2028. This translates to a CAGR of approximately 4.4% during the forecast period.
The Middle East and Africa Therapeutic Dog Food Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Therapeutic Dog Food Market report:
The Middle East and Africa Therapeutic Dog Food Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Therapeutic Dog Food Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Therapeutic Dog Food Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Therapeutic Dog Food Market
